identify you. If you continue to use this site we will assume that you are happy
If you want to use the sites without cookies or would like to know more, you can do that here.
Select regions whose content you would like to see
There are differences in the "commercial dynamics" for developing and marketing 'biosimilar' medicines compared to standard generic drugs and these could be taken into account by competition regulators, an expert has said. 25 May 2017
The Conservative Party has pledged to develop a new "digital charter" for the UK if it is re-elected in the general election on 8 June. 22 May 2017
The pricing of five 'off-patent' cancer drugs by a South Africa-based pharmaceuticals company is being scrutinised by the EU's main competition regulator. 16 May 2017
The Court of Appeal has upheld a junior doctor's argument that he should have been protected by whistleblowing legislation after raising concerns over staffing levels. 10 May 2017
Join My Out-Law
Already signed up to My Out-Law?